Login
← Go Back
Windlas Biotech
WINDLAS · Pharma > Pharmaceuticals & Drugs · Chairman: Vivek Dhariwal · MD: Hitesh Windlass · Listing date: Aug. 17, 2021 · Employees: 1028 · Gurugram · http://windlasbiotech.com
Stock Price vs Company Growth
1d
1.2%
1w
6.1%
1m
18.7%
3m
25.2%
6m
103.0%
1y
186.3%
all
35.3%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,047 1.2%
703
1,143
Company Overview
Sales
661 Cr
Growth: 19.5%
Profit after Tax
59.6 Cr
Growth: 2.4%
Small Cap
2,188 Cr
P/E: 36.6x
Industry P/E: 41.6x
Fundamentals
Sales (Cr) ₹ 661
Growth 19.5%
EBITDA 12.4%
P/S 3.3x
Dividend 1.0%
P/E 36.6x
Book Value ₹ 222
PEG Ratio 1.9x
ROE 13.4%
P/B 4.7x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company provides pharmaceutical development services, large-scale manufacturing services and authentic yet affordable products to its customers and consumers around the world. Awards, accreditations and recognitions2018: The company was awarded the TV100 Industrial Excellence Award in the field of medicine.
Belongs to (4 Indices)
Investors (2)
jainam.b...
samrocks...